Pacer S&P 500 Quality FCF R&D Leaders ETF (QFRD) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Pacer S&P 500 Quality FCF R&D Leaders ETF (QFRD) operates in the Financial Services sector, specifically the Asset Management - Global industry, with a market capitalization near $1.0M, listed on CBOE, carrying a beta of 0.88 to the broader market. A strategy driven exchange traded fund that aims to provide capital appreciation by selecting 50 S&P 500 companies with the highest Research & Development (R&D)expenditures, screened for free cash flow (FCF) quality. Led by William Rhind, public since 2026-01-14.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for QFRD as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.